Stock listing
TPEx:6876 Launxp Biomedical Co., Ltd. (朗齊生醫*) 股價
Follow Launxp Biomedical Co., Ltd. into a list and get an email when it puts out news.
Share price · TPEX:6876
$12.00 TWD -2.05 (-14.6%)
Close on Nov 20, 2026
- Day range
- $11.85 – $13.85 TWDNov 20, 2026
- Volume
- 172,619 sharesNov 20, 2026
- Market cap
- $846.3M TWDAt the close on Nov 20, 2026 · price × 70.53M shares outstanding
- Traded on an average day
- $2.96M TWDMedian day 119,110 shares · 1 day with no trades · last 3 months, Aug 20, 2026 – Nov 20, 2026

Daily closes
Last 3 months, Aug 20, 2026 – Nov 20, 2026 · TPEX:6876 · TWD, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| $12.00 | -2.05 | -14.6% | $13.85 | $13.85 | $11.85 | 172,619 | |
| $14.05 | +0.45 | +3.3% | $13.60 | $14.20 | $13.25 | 157,339 | |
| $13.60 | 0.00 | 0.0% | $13.75 | $13.75 | $13.25 | 156,531 | |
| $13.60 | -0.40 | -2.9% | $14.00 | $14.00 | $13.50 | 60,963 | |
| $14.00 | -0.05 | -0.4% | $14.05 | $14.05 | $13.50 | 76,782 | |
| $14.05 | 0.00 | 0.0% | $14.25 | $14.25 | $13.65 | 102,715 | |
| $14.05 | +0.05 | +0.4% | $14.00 | $14.25 | $13.65 | 124,168 | |
| $14.00 | 0.00 | 0.0% | $14.00 | $14.00 | $12.85 | 114,720 | |
| $14.00 | +1.40 | +11.1% | $12.10 | $14.30 | $12.10 | 864,804 | |
| $12.60 | -0.70 | -5.3% | $13.30 | $13.30 | $12.15 | 112,558 | |
| $13.30 | 0.00 | 0.0% | $13.30 | $13.35 | $13.20 | 265,091 | |
| $13.30 | -0.10 | -0.7% | $13.40 | $13.60 | $12.90 | 272,937 | |
| $13.40 | -0.75 | -5.3% | $14.10 | $14.15 | $12.95 | 109,126 | |
| $14.15 | +0.20 | +1.4% | $13.95 | $14.20 | $12.25 | 528,588 | |
| $13.95 | -0.05 | -0.4% | $13.95 | $13.95 | $13.55 | 7,016 | |
| $14.00 | -0.10 | -0.7% | $14.10 | $14.10 | $13.45 | 16,413 | |
| $14.10 | +0.20 | +1.4% | $14.05 | $14.10 | $13.90 | 47,317 | |
| $13.90 | -0.05 | -0.4% | $14.05 | $14.20 | $13.90 | 89,751 | |
| $13.95 | -0.10 | -0.7% | $13.95 | $13.95 | $13.95 | 0 | |
| $14.05 | -0.45 | -3.1% | $14.40 | $14.45 | $13.95 | 87,306 | |
| $14.50 | 0.00 | 0.0% | $14.00 | $14.70 | $14.00 | 77,376 | |
| $14.50 | +0.50 | +3.6% | $13.95 | $14.50 | $13.95 | 62,140 | |
| $14.00 | -0.95 | -6.4% | $15.05 | $15.05 | $13.95 | 256,085 | |
| $14.95 | -0.10 | -0.7% | $15.05 | $15.05 | $14.90 | 33,753 | |
| $15.05 | -0.20 | -1.3% | $15.25 | $15.25 | $14.95 | 142,743 | |
| $15.25 | 0.00 | 0.0% | $15.25 | $15.50 | $14.90 | 200,904 | |
| $15.25 | 0.00 | 0.0% | $15.20 | $15.75 | $14.60 | 114,073 | |
| $15.25 | +0.05 | +0.3% | $15.40 | $15.40 | $15.00 | 48,846 | |
| $15.20 | +0.10 | +0.7% | $15.35 | $15.55 | $15.05 | 49,603 | |
| $15.10 | -0.80 | -5.0% | $16.05 | $16.05 | $14.95 | 274,943 | |
| $15.90 | +0.05 | +0.3% | $15.90 | $16.20 | $15.50 | 29,618 | |
| $15.85 | -0.10 | -0.6% | $15.95 | $15.95 | $15.25 | 231,510 | |
| $15.95 | +0.15 | +0.9% | $15.45 | $16.00 | $15.40 | 91,317 | |
| $15.80 | 0.00 | 0.0% | $15.50 | $16.00 | $15.45 | 111,792 | |
| $15.80 | -1.10 | -6.5% | $17.05 | $17.05 | $15.50 | 288,264 | |
| $16.90 | -0.45 | -2.6% | $17.40 | $17.40 | $16.90 | 107,446 | |
| $17.35 | +0.15 | +0.9% | $17.30 | $17.50 | $17.00 | 110,108 | |
| $17.20 | +0.50 | +3.0% | $17.00 | $18.10 | $16.65 | 408,913 | |
| $16.70 | +0.70 | +4.4% | $15.55 | $17.45 | $15.55 | 317,530 | |
| $16.00 | +1.55 | +10.7% | $14.70 | $16.05 | $14.70 | 191,692 | |
| $14.45 | +0.05 | +0.3% | $14.55 | $14.55 | $14.25 | 62,953 | |
| $14.40 | -0.15 | -1.0% | $14.55 | $14.55 | $13.50 | 100,482 | |
| $14.55 | +0.05 | +0.3% | $14.50 | $14.55 | $13.95 | 12,755 | |
| $14.50 | -0.55 | -3.7% | $15.05 | $15.05 | $13.35 | 193,612 | |
| $15.05 | -0.35 | -2.3% | $15.50 | $16.30 | $14.50 | 282,137 | |
| $15.40 | -1.45 | -8.6% | $17.35 | $17.35 | $13.95 | 687,139 | |
| $16.85 | -0.55 | -3.2% | $18.00 | $18.25 | $16.55 | 673,174 | |
| $17.40 | +1.75 | +11.2% | $15.80 | $18.35 | $15.40 | 1,170,669 | |
| $15.65 | +1.45 | +10.2% | $15.30 | $16.10 | $14.15 | 691,985 | |
| $14.20 | +2.15 | +17.8% | $11.95 | $14.20 | $11.95 | 217,550 | |
| $12.05 | -0.15 | -1.2% | $12.15 | $12.25 | $11.90 | 139,310 | |
| $12.20 | +0.20 | +1.7% | $11.90 | $12.25 | $11.85 | 42,914 | |
| $12.00 | -0.10 | -0.8% | $12.30 | $12.30 | $11.70 | 118,234 | |
| $12.10 | +0.30 | +2.5% | $11.60 | $12.10 | $11.40 | 91,513 | |
| $11.80 | -0.25 | -2.1% | $12.05 | $12.05 | $11.40 | 163,306 | |
| $12.05 | +0.15 | +1.3% | $11.85 | $12.05 | $11.60 | 63,118 | |
| $11.90 | -0.15 | -1.2% | $12.05 | $12.05 | $11.50 | 171,807 | |
| $12.05 | 0.00 | 0.0% | $11.55 | $12.05 | $11.55 | 40,275 | |
| $12.05 | -0.10 | -0.8% | $12.15 | $12.15 | $11.75 | 133,293 | |
| $12.15 | +0.05 | +0.4% | $11.90 | $12.30 | $11.50 | 166,901 | |
| $12.10 | -0.35 | -2.8% | $12.20 | $12.45 | $11.80 | 549,441 | |
| $12.45 | -0.05 | -0.4% | $12.05 | $12.45 | $11.90 | 119,985 |
- Ticker
- TPEx:6876
- Asset type
- Stock
- Sector
- Health care
- Industry
- Biotechnology
- Exchange
- TPEx
- Currency
- TWD
What changed lately
Latest deck · Mar 18, 2026
Earnings Presentation (March 2026)
Earnings · 37 slides
Launxp Biomedical Co., Ltd. on 6ix
- Sector
- Health care
- Industry
- Biotechnology
- Decks
- 2 decks · latest Mar 18, 2026
Valuation
Price/book 2.3× against a median of 1.6×: 8th lowest of 11 Biotechnology companies shown. balance Jun 30, 2026 · price Nov 20, 2026
- Enterprise value
- $391.1M TWD
- P/E
- Not reported
- EV/sales
- No revenue
- EV/EBITDA
- No depreciation figure on 6ix yet
- Price/book
- 2.3×
- Gross margin
- No revenue
- Operating margin
- No revenue
- Net margin
- No revenue
- Debt to equity
- 0.0×
- Beta
- No index for this market yet
Biotechnology: the 10 companies nearest in size, of 890 on 6ix with figures. Size in US dollars.
| Company | Mkt cap | EV | P/E | EV/Sales | EV/EBITDA | P/B | Net mgn | Debt/Eq | Beta |
|---|---|---|---|---|---|---|---|---|---|
| Launxp Biomedical Co., Ltd. · TPEX:6876 | US$25.67M | US$11.86M | n/a | n/a | n/a | 2.3× | n/a | 0.0× | n/a |
| Edesa Biotech, Inc. · NASDAQ:EDSA | US$27.02M | US$16.72M | n/a | n/a | n/a | 3.1× | n/a | 0.0× | 0.47 |
| Amplia Therapeutics Ltd. · ASX:ATX | US$26.84M | US$8.63M | n/a | n/a | n/a | 1.0× | n/a | 0.0× | n/a |
| Nasus Pharma Ltd. · AMEX:NSRX | US$26.82M | US$15.11M | n/a | n/a | n/a | 2.4× | n/a | 0.0× | 0.99 |
| Telomir Pharmaceuticals, Inc. · NASDAQ:TELO | US$26.82M | US$22.30M | n/a | n/a | n/a | 6.1× | n/a | 0.0× | 1.74 |
| BriaCell Therapeutics Corp · TSX:BCT | US$26.79M | US$6.25M | n/a | n/a | n/a | 1.7× | n/a | 0.0× | 1.07 |
| Alterity Therapeutics Ltd. · ASX:ATH | US$26.76M | US$2.18M | n/a | n/a | n/a | 0.9× | n/a | 0.0× | n/a |
| EyePoint, Inc. · NASDAQ:EYPT | US$26.65M | −US$72.44M | n/a | −28.1× | n/a | 0.3× | n/a | 0.2× | 1.36 |
| Aprogen, Inc · KRX:007460 | US$26.64M | US$21.31M | n/a | 0.2× | n/a | 0.6× | −60.1% | 0.6× | n/a |
| PolTREG Spolka Akcyjna · GPW:PTG | US$26.09M | US$22.35M | n/a | 378× | n/a | 2.2× | n/a | 0.1× | n/a |
| INmune Bio Inc. · NASDAQ:INMB | US$25.60M | US$10.48M | n/a | n/a | n/a | 1.4× | n/a | 0.1× | 2.63 |
| Median of the others | US$26.77M | US$12.80M | 0.2× | 1.6× | −60.1% | 0.0× | 1.22 |
Team and board
Officers
| Officer | Role |
|---|---|
| Aileen Hsu | Chief Financial Officer |
| John Chen | President |
Board
| Director | Role |
|---|---|
| Jeffrey Wang | Chairman of the Board |
| Chia-Chung Chan | Independent Director |
| Chu-yuan Chu | Independent Director |
| John Chen | President |
| Kuo-Bin Lin | Independent Director |
| Li-yun Chen | Director |
| Rui-xing Chen | Director |
| Simon Huang | Director |
| Wen-Sun Tseng | Director |
Decks
| Deck | Kind | Slides | Date |
|---|---|---|---|
| Earnings Presentation (March 2026) | Earnings | 37 slides | Mar 18, 2026 |
| Investor Presentation (October 2024) | Investor deck | 50 slides | October 2024 |
Financials
Annual, in TWD
Income statement
| Line | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|
| Revenue | 2.48M | 11.0K | 0 | 0 |
| Cost of revenue | 199.0K | 0 | 0 | 0 |
| Gross profit | 2.29M | 11.0K | 0 | 0 |
| Research and development | 37.6M | 43.7M | 19.7M | 15.1M |
| Selling, general and administrative | 46.9M | 37.4M | 23.9M | 8.18M |
| Operating income | -82.3M | -81.0M | -43.6M | -34.8M |
| Depreciation and amortization | 2.40M | 2.41M | 2.35M | 1.60M |
| EBITDA | -79.9M | -78.6M | -41.3M | -33.2M |
| Interest expense | 42.0K | 167.0K | 195.0K | 60.0K |
| Income before tax | -82.1M | -80.9M | -43.6M | -34.7M |
| Net income | -82.6M | -80.9M | -43.6M | -34.7M |
| Earnings per share, basic | -2.55 | -2.51 | -1.35 | -1.08 |
Balance sheet
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Cash and equivalents | 98.4M | 179.7M | 15.2M | 34.1M | |
| Short-term investments | 27.0M | ||||
| Receivables | 0 | 9.00K | 0 | ||
| Current assets | 104.9M | 185.5M | 24.2M | 64.2M | |
| Total assets | 123.9M | 206.5M | 32.4M | 73.9M | |
| Accounts payable | 2.38M | 1.94M | 411.0K | 0 | |
| Current liabilities | 13.9M | 21.5M | 7.58M | 5.17M | |
| Total liabilities | 15.0M | 23.2M | 10.2M | 8.65M | |
| Shareholders' equity | 108.9M | 183.3M | 22.2M | 65.2M | |
| Shares outstanding | 48.0M | 32.4M | 32.2M | 32.2M | 32.2M |
Cash flow
| Line | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|
| Cash from operations | -76.7M | -59.1M | -44.2M | -29.0M |
| Capital spending | -316.0K | -3.31M | -804.0K | -4.24M |
| Free cash flow | -77.0M | -62.5M | -45.0M | -33.2M |
| Change in cash | -81.4M | 164.5M | -18.9M | 2.20M |
Cap table
Built by 6ix from Launxp Biomedical Co., Ltd.’s releases
- Common shares
- 70,528,543
- Fully diluted
- 70,528,543
Fully diluted
| Line | Shares |
|---|---|
| Common shares | 70,528,543 |
Share count over time
| Count | Shares |
|---|---|
| Nov 22, 2026 | 70,528,543 |
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| Aileen Hsu | Chief Financial Officer · Since at least Nov 5, 2026 |
| Chia-Chung Chan | Independent Director · Since at least Nov 5, 2026 |
| Chu-yuan Chu | Independent Director · Since at least Nov 5, 2026 |
| Jeffrey Wang | Chairman of the Board · Since at least Nov 5, 2026 |
| John Chen | President · Since at least Nov 5, 2026 |
| Kuo-Bin Lin | Independent Director · Since at least Nov 5, 2026 |
| Li-yun Chen | Director · Since at least Nov 5, 2026 |
| Rui-xing Chen | Director · Since at least Nov 5, 2026 |
| Simon Huang | Director · Since at least Nov 5, 2026 |
| Wen-Sun Tseng | Director · Since at least Nov 5, 2026 |
Log in to ask 6ix AI your own questions about Launxp Biomedical Co., Ltd.